Rational application of gefitinib in NSCLC patients with sensitive EGFR mutations based on pharmacokinetics and metabolomics.
Feng W, Chen X, Guan SX, Ruan HL, Huang Y, Zhang HZ, Yang YP, Fang WF, Zhao HY, Zhuang W, Xin S, Chen YH, Wang F, Gao Y, Huang M, Wang XD, Zhang L.
Feng W, et al. Among authors: xin s.
Acta Pharmacol Sin. 2022 Jul;43(7):1857-1864. doi: 10.1038/s41401-021-00791-5. Epub 2021 Nov 4.
Acta Pharmacol Sin. 2022.
PMID: 34737420
Free PMC article.